Aterian, Inc. (ATER): Nasdaq/NYSE listing notice — Aterian receives Nasdaq bid price deficiency notice; 180-day cure period until June 2026

Aterian, Inc.

Nasdaq notified Aterian on Dec 9, 2025 that closing bid price was below $1.00 for 30 consecutive business days.
Company has until June 8, 2026 to regain compliance by closing at $1.00+ for at least 10 consecutive days.
If not cured, Nasdaq may grant a second 180-day period if Aterian meets other initial listing standards.
Failure to cure could result in delisting; company may appeal to a Nasdaq hearings panel.
No assurance that compliance will be achieved or maintained.

item 3.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Aterian, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5550(a)(2), 5810(c)(3)(A)

Exact text from the filing

December 9, 2025, Aterian, Inc. (the “Company”) received a letter from the Listing Qualifications Staff of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, based upon the closing bid price of the Company’s common stock, par value $0.0001 per share (“Common Stock”), for the last 30 consecutive business days, the Company is not currently in compliance with the requirement to maintain a minimum bid price of $1.00 per share for continued listing on The Nasdaq Capital Market, as set forth in Nasdaq Listing Rule 5550(a)(2) (the “Bid Price Notice”). The Bid Price Notice has no immediate effect

View on SEC.gov

5 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

Aterian, Inc. filing history →

Source: SEC EDGAR

accession 0001437749-25-037738

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.